KRT16P5

Across TCGA pan-cancer cohorts, KRT16P5 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated KRT16P5 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher KRT16P5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KRT16P5 expression acts as an unfavorable survival marker, although some lineages such as ESCA and KIRP show a favorable association.

KICH, UVM, and KIRC are the cancer types where KRT16P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.043	0.971	<.001	99	view →
UVM	DFS	Tertile	All	0.032	0.762	<.001	90	view →
KIRC	DFS	Tertile	III,IV	0.221	0.743	.023	60	view →
TGCT	DFS	Tertile	II,III,IV	0.622	0.978	.016	48	view →
CHOL	DFS	Tertile	All	0.045	0.486	.009	45	view →
ESCA	DFS	Quartile	III,IV	0.562	0.279	.003	39	view →
KIRP	DFS	Tertile	II,III,IV	1.000	0.429	.029	33	view →
THYM	DFS	Median	All	0.982	0.801	.002	25	view →
COAD	OS	Tertile	All	0.217	0.799	.018	18	view →
PAAD	DFS	Tertile	II,III,IV	0.191	0.441	.027	18	view →
OV	OS	Tertile	IV	0.567	0.821	.016	16	view →
LUSC	DFS	Quartile	II,III,IV	0.486	0.209	.021	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

KRT16P5–KICH (DFS)

Open the KICH breakdown →